Stay invested in Sun Pharma: Rajat Bose

Rajat Bose of rajatkbose.com told CNBC-TV18, "I personally holding on and I would suggest that the investor should continue as well because Sun Pharmaceutical recently actually touched a very strong support zone of Rs 500 and I have a feeling that 2009 to about 2015, this seven year or six year bull run corrected by 2.5 year downtrend and that downtrend is already over."

"Now we can expect Sun Pharma to scale up to higher levels. However, before that, Rs 640 to about Rs 650 is the range to watch out for. Once that is decisively taken out, you would see real strong movement in Sun Pharmaceutical. I am talking purely from a technical point of view," he added.